Trial Profile
A Comparative, Open-Label, Randomized, Parallel Group Study to determine Intraperitoneal fluids, tissue, and serum concentrations of VML-0501 following five days of daily vaginal applications of single dose of VML-0501 (100 mg Danazol), in comparison to five days of Danazol treatment administered as an oral capsules (Danatrol) at a daily dose of 600 mg, in two groups of twelve each consisting of women with suspected or confirmed endometriosis and scheduled for laparoscopy
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2020
Price :
$35
*
At a glance
- Drugs Danazol (Primary) ; Danazol
- Indications Endometriosis
- Focus Pharmacokinetics
- Sponsors Viramal
- 06 Nov 2020 Status changed from completed to discontinued.
- 11 Jun 2020 Status changed from active, no longer recruiting to completed.
- 18 May 2020 Planned End Date changed from 28 Feb 2020 to 30 Jun 2020.